Following up on my last posting on advances — and worries — about Artificial General Intelligence… Peter Diamandis’s latest tech blog is regarding AI and ethics.
The whole interview is good and informative but starts with Sinclair commenting that at the moment he thinks living to 150 is possible in our lifetimes but not immortality. But given that, I’m 51. If I’m going to live potentially another century the technology will get better and better in that century and I would fully expect to life spans to become what we want rather than what we have to accept.
In this Ask Me Anything session, David and Peter discuss the latest age-reversal breakthroughs, getting approval from the FDA, and the possibility of living forever. David Sinclair is a biologist and academic known for his expertise in aging and epigenetics. Sinclair is a genetics professor and the Co-Director of Harvard Medical School’s Paul F. Glenn Center for Biology of Aging Research. He’s been included in Time100 as one of the 100 Most Influential People in the World, and his research has been featured all over the media. Besides writing a New York Times Best Seller, David has co-founded several biotech companies, a science publication called Aging, and is an inventor of 35 patents. Read David’s book, Lifespan: Why We Age-and Why We Don’t Have To: https://a.co/d/85H3Mll.
Slowing speed of aging will increase life expectancy.
Peter Diamandis, the founder of the Singularity University and the X Prize Foundation has a goal for the next decade: to add 20 or 30 healthy years to people’s life. Or, in other words, making 100 years old the new 60s. He presents his vision during “Priorities”, a summit that took place on September 2022 in New York and organized by the FII Institute. Here are the highlights.
Excerpt from an interview by Rich Roll to Peter Diamandis, founder and executive officer of XPrize Foundation, co-founder of Singularity University in Silicon Valley, CA., three-time best selling author, public speaker, philanthropist, and prolific investor.
Peter Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education.
In this landmark talk, Peter Diamandis shares how we are rapidly heading towards a human-scale transformation, the next evolutionary step into what he calls a “Meta-Intelligence,” a future in which we are all highly connected — brain to brain via the cloud — sharing thoughts, knowledge and actions. He highlights the 4 driving forces as well as the 4 steps that is transforming humanity.
In 2014 Fortune Magazine named Peter Diamandis as one of the World’s 50 Greatest Leaders.
Peter Diamandis shared an email blast about dire headlines that keep us on edge: the war in Ukraine, food and gasoline prices, climate change, and the neverending pandemic. Getting away from bad news is difficult, it appears, because of the way we are wired. Mass media feeds the bad far more than the good.
In his missive, Peter talks about Matt Ridley, a zoologist, who wrote and published The Rational Optimist in 2010. The book takes a profoundly optimistic view of human progress, a counterblast to the prevailing pessimism of our day. Ridley coined the phrase “moaning pessimism” to describe the current state.
Peter is the founder and executive chairman of the XPRIZE Foundation, and has started over 20 companies in the areas of longevity, space, venture capital and education. He is also the New York Times bestselling author of several books, including his latest, Life Force, which he published early in 2020 with Tony Robbins.
Peter joined host Robert Glazer on the Elevate Podcast to discuss transformational changes needed in education, how the pandemic accelerated global trends, and the astonishing medical and health technologies he believes will be widely available, sooner than you think.
A new photo of Magic Leap 2 appears to show the device’s controller equipped with cameras for inside-out tracking which would be the first time we’ve seen the approach employed in a commercial XR headset.
A recent photo of Magic Leap 2 posted by Peter H. Diamandis is, as far as we know, the first time we’ve gotten a clear look at the front of the Magic Leap 2 controller. The photo clearly shows what appear to be two camera sensors on the controller, indicating a high likelihood it will have on-board inside-out tracking.
The content of Peter’s email blast has been edited by me (can’t help myself). But I believe I have captured its essence and hope you enjoy the retelling. As always your comments are welcomed.
What is Insilico Medicine?
Insilico Medicine is a pioneering drug company that is powered by a “drug discovery engine” that sifts through millions of data samples to determine the signature biological characteristics of specific diseases. It then identifies the most promising treatment targets and uses a new AI technique called generative adversarial networks (GANs) to create molecules perfectly suited against them.